DIRECTORY
BIOTECH
Pharmaclient

   

Quick Click ! Monthly news Home-Site Menu-Site Contactexpress Faqs Legends Companies Events Environment Memories Home-Biotech

Abcys | AB Science | Adocia | Advicenne Pharma | Affichem | Agate Bioservices | Aisa Therapeutics | Alfact Innovation | Alizé Pharma | Ambiotis | Anaconda Pharma | Aptys Pharmaceuticals | Ariana Pharmaceuticals | Aterovax | Atlantic Bone Screen | Aureus Sciences | B Cell Design | BioAlliance Pharma | Biocortech | BioCydex | Biométhodes | Biom'up | BioProtein Technologies | BioQuanta | BioSystems International | BMSystems (Bio-Modeling) | Carmat | Cellectis | Cellial Technologies | CellProthera | CellVax | Cerenis Therapeutics | CliniGenetics | Covalab | Cytheris | Cytoo | DBV Technologies | Diaxonhit | DNA Therapeutics | Domain Therapeutics | Dynabio | Edelris | Endotis Pharma | Epixis | ERYtech Pharma | Eye Tech Care | Flamel Technologies | Fluofarma | GemacBio | Genepep | Genewave | Genfit | Genomic Vision | GenoSafe | GenoScience Pharma | Genoscreen | GenOway | Genticel | GTP Technology | Helios Biosciences | Hemarina | Hybrigenics | Hyphen BioMed | Imagene | ImmunId | Immutep | Imstar | In-Cell-Art | Indicia Biotechnology | InGen Biosciences | Innate Pharma | InnaVirVax | Innovative Health Diagnostics | IntegraGen | Ipsogen | I-Stem | Karcinolys | Keosys | MABlife | Magnisense | Mapreg | Mauna Kea Technologies | Medesis Pharma | Mellitech | Metabolys | MilleGen | Murigenetics | NanoBiotix | Neorphys | Neovacs | Netris-Pharma | Neuronax | NewVectys | NicOx | Nokad | Nosopharm | NovAliX | NovoCIB | Novotec | Obe Therapy | Oligovax | Oncodesign | OriBase Pharma | Oroxcell | Oxincell | Palumed | PharmaLeads | Pharnext | PhenoPro | Pherecydes Pharma | PolyIntell | Proteogenix | Protexel | PX'Therapeutics | Quantum Genomics | Rhenovia Pharma | ScarCell Therapeutics | Sisène Biotechnologies | Skuld-Tech | Stentys | Synapcell | Synprosis | Tc Land Expression | Theraclion | Theradiag | Theralpha | TheraVectys | Transgene | Trophos | TxCell | UROsphere | Vaxon Biotech | Vectalys | Vivalis | XenTech |

* PX'THERAPEUTICS *


 

2000 - Rhône-Alpes
Grenoble
www.px-therapeutics.com

 

Contract; Research
(also, Contract, Manufacturing)
Key words: Recombinant protein engineering
Mission: to develop biotherapeutics (valuable recombinant proteins) from early stage research up to cGMP production through its specialized technology and manufacturing platforms Protein'eXpert, PX'Monoclonals and PX'Pharma, for third parties
Clients: Pharmaceutical industry, Biotechs
marketing@px-therapeutics.com

Age: 16 year(s)

 

 

Identity
TYPE/MANAGEMENT/INVESTORSFINANCES/STATUS

Personal venture |
Managing Dir.-CEO: Rousselle (Tristan) [co-founder, born 1970, Ph.D. cellular biology]
Sc.Dir.-CSO: Mouz (Nicolas) [co-founder, born 1966, Ph.D. molecular biology]
Prod.Dir.-CTO: Mouz (Sebastien) [Ph.D.]
Fin.Dir.-CFO:
BusDev: Untereiner (Claire)
Financers (Hist.): Vizille Capita (and others), privately owned (registered capital 2007= 0.13 M€)

Turnover (M€) : 3.28 (2009), 2.62 (2008), 2.8 (2007)
Total funding (M€) : n.a.
Last funding (M€) : 1.3
Focus : Multiple
Position : Trade
Company confirm : none

 

History
DATEMILESTONETYPETIME
2012 .10 Acquisition by Aguettant (majority stake, but non-operational), co-founders still managing company ACQ- [11 years]
2012 .03 Clinical trial (phase I) for EuroNeut-41 Prophylactic HIV Vaccine in healthy female volunteers (beginning) CLIN [11 years]
2011 .00 Licensing-in from Ribovax (Switzerland) of Sebvi technology for the development and manufacturing of fully human monoclonal antibodies LICIN [10 years]
2010 .12 Production : new additional biomanufacturing unit, dedicated to mammalian cell culture production (opening facility) INDUS [10 years]
2010 .08 Set-up of new subsidiary Promise Advanced Proteomics, offering unique protein Absolute Quantification services ORGC [9 years]
2009 .11 Production : new additional biomanufacturing unit, dedicated to the production of therapeutic proteins and monoclonal antibodies in mammalian cells, in Grenoble (10th anniversary) INDUS [9 years]
2008 .10 Partnering manufacturing agreement with Alizé Pharma on a recombinant L-asparaginase INDUS [7 years]
2008 .09 Company name change from ProteineXpert to PX'Therapeutics, in order to highlight its focus on integrated biotherapeutics development and to avoid labeling confusions INFO [7 years]
2008 .07 Partnering co-commercialization agreement with Althea Technologies (San Diego, USA) MKTG [7 years]
2007 .07 Set-up of PX'Monoclonals subsidiary in Lyon, dedicated to the development of murine and humanized monoclonal antibodies for research and therapeutic purposes ORGC [6 years]
2004 .09 Set-up of PX'Pharma subsidiary to provide with cGMP clinical manufacturing services ORGC [3 years]
2003 .11 Round-financing : 1.3 M€, by undisclosed regional investors RFIN [3 years]
2000 .11 Company founded by Tristan Rousselle and Nicolas Mouz ORGF [0 year]

Actualisation / Updating: 6-Dec-2012

   


Pharmaclient est le site-conseil de la Valorisation Client en Pharma...
Pour toute Mission, Inscription à la Pharmagalerie, Insertion dans la base Biotech, ou Question: CONTACT



© J.H. Huber, Pharmaclient 2001-2017. Pour retourner à la page d'accueil Biotech: BIENVENUE !       Haut de page : légende